![Sona Saira Ramasastry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 148 968 $ au 30/06/2026
Sona Saira Ramasastry is the founder of Life Sciences Advisory LLC, founded in 2009, holding the title of Managing Partner.
Ms. Ramasastry is also the founder of Sanacor, Inc...
Current jobs include Independent Non-Executive Director at Glenmark Pharmaceuticals Ltd. since 2019, Independent Director at Mirum Pharmaceuticals, Inc. since 2022, Director at Elevian, Inc., Director at DOT Therapeutics-2, Inc. since 2021, Director at Faeth Therapeutics, Inc. starting 2026, Member at Aspen Global Leadership Network, and Head-Business & Sustainability at European Prevention of Alzheimer's Dementia Consortium.
Former jobs include Independent Director at Repros Therapeutics, Inc. from 2013 to 2018, Independent Director at Sangamo Therapeutics, Inc. from 2012 to 2022, Independent Director at Filana Therapeutics, Inc. from 2013 to 2020, Director at American Liver Foundation, Director at Pain Therapeutics, Inc. from 2013 to 2020, Independent Director at Akouos, Inc. from 2020 to 2022, Independent Director at 9 Meters Biopharma, Inc. from 2018 to 2020, Independent Director at Day One Biopharmaceuticals, Inc. from 2021 to 2026, Independent Director at Vir Biotechnology, Inc. from 2019 to 2026, and Financial Analyst at Wasserstein Perella & Co., Inc. from 1997 to 1998.
Education includes undergraduate and graduate degrees from Stanford University and a graduate degree from the University of Cambridge.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 14 619 ( 0,01% ) | 148 968 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| GLENMARK PHARMACEUTICALS LIMITED | Directeur/Membre du Conseil | 01/04/2019 |
| MIRUM PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 02/06/2022 |
| FAETH THERAPEUTICS, INC. | Directeur/Membre du Conseil | 12/06/2026 |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drugs | Directeur/Membre du Conseil | 12/04/2021 |
European Prevention of Alzheimer's Dementia Consortium | Corporate Officer/Principal | - |
Elevian, Inc.
 Elevian, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures regenerative medicines that target root-cause aging mechanisms | Directeur/Membre du Conseil | - |
Life Sciences Advisory LLC | Directeur Général | 01/04/2009 |
Aspen Global Leadership Network | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Directeur/Membre du Conseil | 26/05/2026 |
| ░░░ ░░░ ░░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 20 |
|---|---|
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat hormonal and reproductive system disorders | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Cassava Sciences, Inc.
 Cassava Sciences, Inc. BiotechnologyHealth Technology Manufactures and markets therapeutic products to detect and treat neurodegenerative diseases | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Glenmark Pharmaceuticals Ltd.
 Glenmark Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Liver Foundation
 American Liver Foundation Miscellaneous Commercial ServicesCommercial Services Engages in facilitate, advocate and promote education, support and research for the prevention, treatment & cure of liver disease | Commercial Services |
Wasserstein Perella & Co., Inc.
 Wasserstein Perella & Co., Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Life Sciences Advisory LLC | |
Aspen Global Leadership Network | |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Akouos, Inc.
 Akouos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a genetic medicine company that develops adeno-associated viral vector-based gene therapies for sensorineural hearing loss | Commercial Services |
9 Meters Biopharma, Inc.
 9 Meters Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for people with rare digestive diseases and gastrointestinal conditions | Health Technology |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
Pain Therapeutics, Inc.
 Pain Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Develops drugs | Health Technology |
Elevian, Inc.
Elevian, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures regenerative medicines that target root-cause aging mechanisms | Health Technology |
European Prevention of Alzheimer's Dementia Consortium | |
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drugs | Health Technology |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Day One Biopharmaceuticals, Inc.
 Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
